The results showed that in BRCA, CESC, CHOL, COAD, ESCA, HNSC, LIHC, LUAD, LUSC, READ, STAD and UCEC, the expression level of SLMO2 was significantly higher in tumor stage compared with normal tissues. This evidence concerns the gene PRELID3B and neoplasm.